PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

An engineered protein enhances memory

Researchers from the Faculty of Medicine and Surgery at the Catholic University, Rome and the Fondazione Policlinico Universitario A. Gemelli IRCCS have developed an engineered protein that boosts memory

2023-11-15
(Press-News.org) Neuroscientists at the Faculty of Medicine and Surgery of the Catholic University, Rome, and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS have genetically modified a molecule, the protein LIMK1, which is normally active in the brain, with a key role in memory. They added a "molecular switch" that is activated by administering a drug, rapamycin, known for its several anti-aging effects on the brain.

This is the result of a study published in the journal Science Advances, which involves the Catholic University, Rome, and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The study was coordinated by Claudio Grassi, Full Professor of Physiology and Director of the Department of Neuroscience.

The research, supported by the Italian Ministry of Education, University and Research, the American Alzheimer's Association Foundation, and the Italian Ministry of Health, has great potential applications, by improving our understanding of memory function and facilitating the identification of innovative solutions for neuropsychiatric diseases like dementia.

The LIMK1 protein plays a crucial role in determining structural changes in neurons, namely the formation of dendritic spines, which enhance information transmission in neural networks and are crucial in learning and memory processes.

Prof. Claudio Grassi, senior author of the study, explains: "Memory is a complex process that involves modifications in synapses, which are the connections between neurons, in specific brain areas such as the hippocampus, which is a neural structure playing a critical role in memory formation. This phenomenon, known as synaptic plasticity, involves changes in the structure and function of synapses that occur when a neural circuit is activated, for example, by sensory experiences. These experiences promote the activation of complex signaling pathways involving numerous proteins" Prof. Grassi adds. "Some of these proteins are particularly important for memory, in fact reduced expression or modifications of these proteins are associated with alterations in cognitive functions. One of these proteins is LIMK1. The goal of our study was to regulate the activity of this protein, as it plays a key role in the maturation of dendritic spines between neurons. Controlling LIMK1 with a drug means being able to promote synaptic plasticity and, therefore, the physiological processes that depend on it," Prof. Grassi emphasizes.

Cristian Ripoli, Associate Professor of Physiology at the Catholic University, and first author of the study, adds: "the key to this innovative 'chemogenetic' strategy, which combines genetics and chemistry, is precisely linked to the use of rapamycin", an immunosuppressive drug known to increase life expectancy and for its beneficial effects on the brain, in preclinical models. "We have therefore modified the sequence of the LIMK1 protein by inserting a molecular switch that allowed us to activate it, on command, through the administration of rapamycin" Prof. Ripoli emphasizes. "In animals with age-related cognitive decline, using this gene therapy to modify the LIMK1 protein and activate it with the drug resulted in a significant memory improvement. This approach allows us to manipulate synaptic plasticity processes and memory in physiological and pathological conditions. Furthermore, it paves the way for the development of further 'engineered' proteins that could revolutionize research and therapy in the field of neurology," the expert emphasizes. "The next step will be to verify the effectiveness of this treatment in experimental models of neurodegenerative diseases exhibiting memory deficits, such as Alzheimer's disease. Further studies will also be necessary to validate the use of this technology in humans" Prof. Grassi concludes.

 

END



ELSE PRESS RELEASES FROM THIS DATE:

New near-complete skeleton of a bird-like dinosaur is found in a position which suggests it slept like modern birds

New near-complete skeleton of a bird-like dinosaur is found in a position which suggests it slept like modern birds
2023-11-15
New near-complete skeleton of a bird-like dinosaur is found in a position which suggests it slept like modern birds ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0293801 Article Title: A new alvarezsaurid dinosaur (Theropoda, Alvarezsauria) from the Upper Cretaceous Baruungoyot Formation of Mongolia provides insights for bird-like sleeping behavior in non-avian dinosaurs Author Countries: Japan, Mongolia Funding: Funding for this project was granted by Research Fellowships from the Japan Society for the Promotion of Science (JSPS 21J12938) (to KK) and Ami Koshimizu (Endless Glory Office Restart Co., Ltd.) (to KK). The funders had ...

Radiocarbon dating meets Egyptology and Biblical accounts in the city of Gezer

Radiocarbon dating meets Egyptology and Biblical accounts in the city of Gezer
2023-11-15
New dates provide detailed insights into the timing of events in the ancient city of Gezer, according to a study published November 15, 2023 in the open-access journal PLOS ONE by Lyndelle Webster of the Austrian Academy of Sciences and colleagues. Gezer is an ancient southern Levantine city, well known from Egyptian, Assyrian, and Biblical texts and associated with stories of power struggles and significant historical figures. It is also a rich archaeological site with abundant Bronze Age and Iron Age remains and with great potential for research into the daily lives of its denizens. Recent excavations at the site have uncovered a continuous stratigraphic ...

Women with breast cancer take sexual health into their own hands

Women with breast cancer take sexual health into their own hands
2023-11-15
A third of users on a popular breast cancer support forum describe using peer-recommended or self-discovered techniques to improve sexual functioning, according to a study published November 15, 2023 in the open-access journal PLOS ONE by Christiana von Hippel from the Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, USA, and colleagues. Over 75 percent of breast cancer survivors describe experiencing some degree of sexual dysfunction. Commonly prescribed interventions such as vaginal lubricants or numbing creams are only moderately ...

Australian footprints are the oldest known evidence of birds from southern regions

Australian footprints are the oldest known evidence of birds from southern regions
2023-11-15
Early birds had made it to southern polar environments by 120 million years ago, according to a study published November 15, 2023 in the open-access journal PLOS ONE by Anthony Martin of Emory University, USA and colleagues. Cretaceous bird fossils are abundant and diverse in northern continents, but extremely rare in southern continents, regions that were once part of the landmass of Gondwana. This presents a challenge for paleontologists trying to understand the distribution of early birds. In this study, Martin and colleagues report ...

Treatment strategy for certain advanced prostate cancers shows promise in preclinical models

2023-11-15
Study Title: Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer Publication: Science Translational Medicine [10.1126/scitranslmed.adf6732] Dana-Farber Cancer Institute author: Himisha Beltran, MD Summary: Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks. This process is mediated by molecules called DNA methyltransferases. These tags can alter gene expression in ways that promote tumors to grow and transition ...

Devil in the detail – What corporations aren’t disclosing about their C02 emissions

2023-11-15
A new study estimates most corporations are not reporting the full scope of their carbon footprint with many claiming to be ‘green’ despite a lack of reporting on Scope 3 key categories. Though CO2 reporting is currently voluntary for most firms, corporations are under pressure from investors, regulators, politicians, non-profit organisations and other stakeholders to disclose and reduce greenhouse gas emissions (GHG). The standard for greenhouse gas accounting, the Greenhouse Gas Protocol, is used worldwide to measure a company’s total carbon footprint with three levels of reporting. The first measures the GHG emissions directly produced by a company ...

New ‘patch’ uses natural body motion to fix disc herniation

New ‘patch’ uses natural body motion to fix disc herniation
2023-11-15
PHILADELPHIA— A new biologic “patch” that is activated by a person’s natural motion could be the key to fixing herniated discs in people’s backs, according to researchers at the Perelman School of Medicine at the University of Pennsylvania and the CMC VA Medical Center (CMCVAMC). Combining years of work from many different projects, the “tension-activated repair patches” (TARPs) provide controlled release of an anti-inflammatory molecule called anakinra from microcapsules over time, which helped ...

The liking gap is real for second language English speakers, new Concordia research shows

The liking gap is real for second language English speakers, new Concordia research shows
2023-11-15
A new study from Concordia’s Applied Linguistics Lab suggests that most people are usually overly harsh on themselves when speaking in a second language. Writing in the journal Languages, PhD student Rachael Lindberg and her co-authors build on the previous understanding of individuals’ metaperception—a person’s idea of how they are perceived by others. The idea that people frequently underestimate how likeable they are, known as the Liking Gap, ...

Study reveals link between neighborhood environmental burden and risk of cardiovascular disease

2023-11-15
BOSTON – A national study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) demonstrates that neighborhood exposure to environmental hazards is significantly associated with poor cardiovascular health across the United States. The study, presented at the American Heart Association Scientific Sessions and simultaneously published in JAMA Cardiology, found that greater cumulative environmental burden (e.g., air pollution, nearby hazardous/toxic sites, poor built environment) was linked ...

Cancer: Discovery of the mechanisms regulating cancer formation

2023-11-15
To form a cancer, cells need to accumulate oncogenic mutations that confer tumor-initiating properties. However, recent evidence has shown that oncogenic mutations occur at a surprisingly high frequency in normal tissues, suggesting that mutations alone are not sufficient to drive cancer formation and that other mechanisms should promote or restrain oncogene-expressing cells from progressing into invasive tumors. In a study published in Nature, researchers led by Prof. Cédric Blanpain, MD/PhD, investigator of the WEL Research Institute, Director of the Stem Cells and Cancer Laboratory and Professor at the Université ...

LAST 30 PRESS RELEASES:

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care

Nerve block may reduce opioid use in infants undergoing cleft palate surgery

CRISPR primes goldenberry for fruit bowl fame

Mass General Brigham announces new AI company to accelerate clinical trial screening and patient recruitment

Fat tissue around the heart may contribute to greater heart injury after a heart attack

Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

Cartilaginous cells regulate growth and blood vessel formation in bones

Plant hormone allows lifelong control of proteins in living animal for first time

[Press-News.org] An engineered protein enhances memory
Researchers from the Faculty of Medicine and Surgery at the Catholic University, Rome and the Fondazione Policlinico Universitario A. Gemelli IRCCS have developed an engineered protein that boosts memory